Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · IEX Real-Time Price · USD
4.310
-0.130 (-2.93%)
At close: Jul 19, 2024, 4:00 PM
4.350
+0.040 (0.93%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Elicio Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Elicio Therapeutics stock has a target of 10, which predicts an increase of 132.02% from the current stock price of 4.31.
Analyst Consensus: Buy
* Price targets were last updated on Jun 6, 2024.
Analyst Ratings
The average analyst rating for ELTX stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +132.02% | Jun 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +132.02% | May 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +132.02% | May 1, 2024 |
| Oppenheimer | Oppenheimer | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +155.22% | Jan 17, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.75
from -6.96
EPS Next Year
-3.13
from -3.75
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.75 | -2.92 | -3.29 |
| Avg | -3.75 | -3.13 | -3.19 |
| Low | -3.70 | -3.28 | -3.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.